Get the latest Science News and Discoveries

AI-driven molecular glue innovation: Insilico nominates ISM9546, an oral, peripheral-restricted VAV1 degrader as PCC for autoimmune diseases

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Related news:

‘Remarkably encouraging’: stem-cell treatments for autoimmune diseases enter new phase

Insilico launches AI-driven longevity vaccines research for aging-related diseases and human longevity

Nature Biotechnology | Insilico’s AI-driven IPF candidate rentosertib shows potential for biological age reversal, as assessed by six proteomic aging clocks

« Bigger data reveals the second, third and fourth switches controlling a gene

Autonomous vehicles learn to cooperate in complex traffic »